Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01413529 · ClinicalTrials.gov registry record · Phase 2
HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT01413529 is a Phase 2 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 35 participants.
The verdict
NCT01413529, a Phase 2 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
HIV infected drug users have greater difficulty adhering to highly active antiretroviral therapy compared to non-drug users. As sustained adherence to highly active antiretroviral therapy is critical to reducing HIV related morbidity, mortality, and reducing the spread of HIV, innovative and potentially sustainable treatment strategies that can optimize the durability of adherence enhancing interventions among drug users is urgently needed. The goal of this study is to further develop and pilot test a smartphone based intervention called HEART (Helping Enhance Adherence to Retroviral therapy using Technology) to HAART, to enhance adherence to HAART among HIV infected drug users.
Interventions
- BEHAVIORAL HEART to HAART
- BEHAVIORAL adherence counseling with the addition of smartphone control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01413529
The ClinicalTrials.gov registry entry for NCT01413529 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HEART to HAART is the first listed.
NCT01413529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01413529 about?
NCT01413529 is a clinical study titled "HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users". HIV infected drug users have greater difficulty adhering to highly active antiretroviral therapy compared to non-drug users. As sustained adherence to highly active antiretroviral therapy is critical to reducing HIV related morbidity, mortality, and reducing the spread of HIV, innovative and potenti...
What is the current status of trial NCT01413529?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2011-09. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01413529?
The interventions under investigation include: HEART to HAART (BEHAVIORAL), adherence counseling with the addition of smartphone control (BEHAVIORAL).
Who is sponsoring clinical trial NCT01413529?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.